tiprankstipranks
Trending News
More News >

Peter DeMuth Insider Profile

4 Followers
Peter DeMuth, CSO at Elicio Therapeutics, holds 743.00 shares in Elicio Therapeutics (Ticker: ELTX).
tipranks
Peter DeMuth

Peter DeMuth
Elicio Therapeutics (ELTX)
CSO

Not Ranked
Peter DeMuth has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$6K
100.00%
A breakdown of Peter DeMuth's holdings

Insider Roles

Elicio Therapeutics
(ELTX)
CSO
Roles that Peter DeMuth holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Peter DeMuth

Peter DeMuth's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Elicio Therapeutics
Dec 10, 2025
CSO
Uninformative Buy
1.60K
$6.08K
Peter DeMuth has not reported any informative transactions for ELTX, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 18, 2024
Uninformative Buy
$1.68K
-
$4.41
Dec 10, 2025
Uninformative Buy
$1.60K
-
$4.41
List of latest transactions for each holding click on a transaction to see Peter DeMuth's performance on stock

Peter DeMuth insider profile FAQ

What is the percentage of profitable transactions made by Peter DeMuth?
The percentage of profitable transactions made by Peter DeMuth is ―.
    What is the average return per transaction made by Peter DeMuth?
    The average return per transaction made by Peter DeMuth is ―.
      What stocks does Peter DeMuth hold?
      Peter DeMuth holds: ELTX stocks.
        What was Peter DeMuth’s latest transaction?
        Peter DeMuth latest transaction was an Uninformative Buy of $1.60K.
          What was Peter DeMuth's most profitable transaction?
          Peter DeMuth’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Peter DeMuth's role in Elicio Therapeutics?
            Peter DeMuth's role in Elicio Therapeutics is CSO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.